| 596 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell injury/death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 597 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and reduced cell growth |
You Song |
BY-SA |
None
|
None
|
|
|
| 598 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and reduced cell proliferation |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 599 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and cell injury/death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 600 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and reduced cell growth |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 601 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and reduced cell proliferation |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 602 |
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 603 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell cycle disruption |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 613 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via increased reactive oxygen species production |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 612 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via reduced adenosine triphosphate |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 606 |
Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1 |
You Song |
BY-SA |
2374: Increase, Ecdysone receptor antagonism
|
2 AOs
|
|
|
| 624 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 625 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 626 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 627 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 628 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 629 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 630 |
Decreased 11β-Hydroxysteroid dehydrogenase type 2 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2409: Decrease, 11β-Hydroxysteroid dehydrogenase type 2 activity
|
None
|
Under Development |
|
| 631 |
Decreased thyroid hormone receptor beta transcriptional activity leading to MASLD progression via endoplasmic reticulum stress |
You Song |
BY-SA |
None
|
None
|
|
|
| 632 |
Increased adrenal glucocorticoid production leading to MASLD progression (3) |
You Song |
BY-SA |
None
|
None
|
|
|
| 633 |
Increased adrenal glucocorticoid production leading to MASLD progression (4) |
You Song |
BY-SA |
None
|
None
|
|
|
| 634 |
Increased adrenal glucocorticoid production leading to MASLD progression (5) |
You Song |
BY-SA |
None
|
None
|
|
|
| 635 |
Increased adrenal glucocorticoid production leading to MASLD progression (6) |
You Song |
BY-SA |
None
|
None
|
|
|
| 286 |
Mitochondrial complex III antagonism leading to growth inhibition (1) |
You Song |
BY-SA |
1542: Inhibition, Mitochondrial complex III
|
1521: Decrease, Growth
|
|
|
| 341 |
DNA methyltransferase inhibition leading to transgenerational effects (2) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|